CORONA REMEDIES
|
The Current P/S Ratio of CORONA REMEDIES is 9.37.
| Share Price | ₹2,067.3 | Jul 16,2026 |
| Market Cap | ₹12,651.6 Cr | |
| Sales-TTM | ₹1,350.3 Cr | TTM-Consolidated Results |
| Price/Sales | 9.37x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of CORONA REMEDIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹12,651.6 Cr] as on Jul 16,2026
(/) Sales [ ₹1,350.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 9.37x ]
Thus, for CORONA REMEDIES , the investors are currently willing to pay '9.37 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CORONA REMEDIES !
The chart below summarizes the trend in P/S Ratio of CORONA REMEDIES over the last five years.
Historical PS (Price/Sales) ratio chart of CORONA REMEDIES
PS Ratio Performance Analysis for CORONA REMEDIES
- CORONA REMEDIES 's p/e ratio for fiscal years ending Mar2026 to Mar2023 averaged 1.70x.
- CORONA REMEDIES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, CORONA REMEDIES 's p/e ratio peaked in Mar2026 at 6.78x.
- CORONA REMEDIES 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does CORONA REMEDIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| CORONA REMEDIES | 1,350.3 | 9.37 | 12,651.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 8.00 | 467,870.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 18.40 | 194,316.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 12.11 | 169,316.0 |
| CIPLA LTD | 28,162.6 | 4.10 | 115,477.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.03 | 102,156.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.36 | 105,107.0 |
| LUPIN LTD | 27,958.0 | 4.09 | 114,311.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.24 | 115,062.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.65 | 89,074.2 |
| LAURUS LABS LTD | 6,812.9 | 12.35 | 84,149.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CORONA REMEDIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.65x |
| Max industry PS | 18.40x |
| Median industry PS | 7.36x |
| Average industry PS | 7.79x |
You may also like the below Video Courses